Epigenic Therapeutics is a startup based in Israel, 2 tracked investors.
Epigenic Therapeutics is a company founded in 2020 headquartered in Israel. Brouky records 2 investors associated with the company.
Epigenic Therapeutics develops epigenetic gene-modulation therapies using its proprietary EPIREG platform, which applies AI-optimized CRISPR-based components to regulate target gene expression without changing DNA sequence for treatment of human diseases.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.